REST: An oncogene or a tumor suppressor?

Trends in Cell Biology

Volumn 23, Issue 6, 2013, Pages 289-295

  Negrini, Sara ^a   Prada, Ilaria ^a   D'Alessandro, Rosalba ^b   Meldolesi, Jacopo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b S De Bellis Scientific Institute   (Italy)

Author keywords

Blastoma; Carcinoma; Cell proliferation; Molecular mechanisms; New cancer therapy; NRSF

Indexed keywords

REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; RE1-SILENCING TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CARCINOGENESIS; CELL PROLIFERATION; CELL TYPE; COLON CARCINOMA; GLIOBLASTOMA; HUMAN; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MEDULLOBLASTOMA; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROBLASTOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; CARCINOMA; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; STEM CELL;

CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MEDULLOBLASTOMA; NEUROBLASTOMA; NEURONS; ONCOGENES; REPRESSOR PROTEINS; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 84878138458     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.01.006     Document Type: Review

References (67)

1. Ballas N., Mandel G. The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 2005, 15:500-506.
2. Ooi L., Wood I.C. Chromatin crosstalk in development and disease: lessons from REST. Nat. Rev. Genet. 2007, 8:544-554.
3. Raj B., et al. Cross-regulation between an alternative splice activator and a transcription repressor controls neurogenesis. Mol. Cell 2011, 43:843-850.
4. Magin A., et al. RE-1 silencing transcription factor-4 (REST4) is neither a transcriptional repressor nor a de-repressor. Neurochem. Int. 2002, 40:195-202.
5. Calderone A., et al. Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 2003, 23:2112-2121.
6. Jessberger S., et al. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J. Neurosci. 2007, 27:5967-5975.
7. Tischler A.S., et al. Nerve growth factor is a potent inducer of proliferation and neuronal differentiation for adult rat chromaffin cells in vitro. J. Neurosci. 1993, 13:1533-1542.
8. Gianani R. β-Cell regeneration in human pancreas. Semin. Immunopathol. 2011, 33:23-27.
9. Fuller G.N., et al. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron restrictive silencer factor, which can be functionally countered by REST-VP16. Mol. Cancer Ther. 2005, 4:343-349.
10. Su X., et al. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol. Cell. Biol. 2006, 26:1666-1678.
11. Zhang P., et al. Nontelomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells. Curr. Biol. 2008, 18:1489-1494.
12. β-TRCP in neuroblastoma cells. Cancer 2011, 117:5189-5202.
13. Tomasoni R., et al. A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cells. J. Cell Sci. 2011, 124:3174-3186.
14. Kamal M.M., et al. REST regulates oncogenic properties of glioblastoma stem cells. Stem Cells 2012, 30:405-414.
15. Conti L., et al. REST controls self-renewal and tumorigenic competence of human glioblastoma cells. PLoS ONE 2012, 7:e38486.
16. Majumder S. REST in good times and bad. Roles in tumor suppressor and oncogenic activities. Cell Cycle 2006, 5:1929-1935.
17. Westbrook T.F., et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 2005, 121:837-848.
18. Coulson J.M. Transcriptional regulation: cancer, neurons and the REST. Curr. Biol. 2005, 15:R665-R668.
19. Lv H.P.G., et al. Expression and functions of the repressor element 1 (RE-1)-silencing transcription factor (REST) in breast cancer. J. Cell. Biochem. 2010, 110:968-974.
20. Wagoner M.P. The transcription factor REST is lost in aggressive breast cancer. PLoS Genet. 2010, 6:e1000979.
21. Gurrola-Diaz C., et al. Reduced expression of the neuron restrictive silencer factor permits transcription of glycine receptor α1 subunit in small cell lung cancer cells. Oncogene 2003, 22:5636-5645.
22. Kreisler A., et al. Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer. Oncogene 2010, 29:5828-5838.
23. Yang L., et al. A tumor suppressor and oncogene: the WT-1 story. Leukemia 2007, 21:868-876.
24. Rowland B.D., Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 2006, 6:11-23.
25. Blyth K., et al. The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 2005, 5:376-587.
26. Lamouille S., Derynck R. Oncogene and tumor suppressor: the two faces of SnoN. EMBO J. 2009, 28:3459-3460.
27. Hatano Y., et al. Genetic ablation of a candidate tumor suppressor gene, REST, does not promote mouse colon carcinogenesis. Cancer Sci. 2011, 102:1659-1664.
28. Das C.M., et al. The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation. Oncogene 2012, 10.1038/onc.2012.182.
29. Huang X., et al. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry. Mol. Cell 2011, 42:511-523.
30. Wagoner M.P., Roopra T. The REST-derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease. BMC Genomics 2012, 13:686.
31. Conaco C., et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2422-2427.
32. Silber J., et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
33. Fowler A., et al. miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur. J. Cancer 2011, 47:953-963.
34. Xia H., et al. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem. 2012, 287:9962-9971.
35. D'Alessandro R., et al. Expression of the neurosecretory process in PC12 cells is governed by REST. J. Neurochem. 2008, 105:1369-1383.
36. Nishihara S., et al. The canonical Wnt pathway directly regulates REST/NRSF expression in chick spinal cord. Biochem. Biophys. Res. Commun. 2003, 311:55-63.
37. Jozwiak J., Wlodarski P. Hamartin and tuberin modulate gene transcription via β-catenin. J. Neurooncol. 2006, 79:229-234.
38. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 1984, 103:285-293.
39. Bariawno N., et al. Small molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/β-catenin pathway cross-talk and suppress medulloblastoma growth. Cancer Res. 2010, 70:266-276.
40. Laplante M., Sabatini D.M. mTor signaling in growth control and disease. Cell 2012, 149:274-293.
41. Chang L., et al. Expression, regulation and metastasis-promoting protein InsP3-kinase-A in tumor cells. Mol. Cancer Res. 2011, 9:497-506.
42. Mulligan P., et al. CDYL bridges REST and histone methyltransferase for gene repression and suppression of cellular transformation. Mol. Cell 2008, 32:718-726.
43. βTRPC controls oncogenic transformation and neural differentiation through REST degradation. Nature 2008, 452:370-374.
44. Thornton J.E., Gregory R.I. How does Lin28 let-7 control development and disease?. Trends Cell Biol. 2012, 22:474-481.
45. Gunsalus K.T.W., et al. Induction of the RNA regulator Lin28A is required for the growth and pathogenesis of RESTless breast tumors. Cancer Res. 2012, 72:3207-3216.
46. Moss A.C., et al. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer. Clin. Cancer Res. 2009, 15:274-283.
47. Sanson M., et al. Molecular changes in brain tumors: prognostic and therapeutic impact. Curr. Opin. Oncol. 2006, 18:623-630.
48. Taylor P., et al. REST is a novel prognostic factor and therapeutic target for medulloblastomas. Mol. Cancer Ther. 2012, 11:1713-1723.
49. Zhang P., et al. Squelching glioblastoma stem cells by targeting REST for proteasomal degradation. Trends Neurosci. 2009, 11:559-565.
50. Berendsen S., et al. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results. Expert Opin. Investig. Drugs 2012, 21:1391-1415.
51. Hummel R., et al. MicroRNAs in brain tumors: a new diagnostic and therapeutic perspective?. Mol. Neurobiol. 2011, 44:223-234.
52. Donev R.M., et al. Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy of neuroblastomas. Cancer Res. 2008, 68:5979-5987.
53. Califano R., et al. Management of small cell lung cancer: recent developments for optimal care. Drugs 2012, 72:471-490.
54. Spigel D.R., et al. Phase II study of maintenance sunitinib following irinotecan and carboplatin as first line treatment for patients with extensive stage small-cell lung cancer. Lung Cancer 2012, 77:359-364.
55. Planchard D., Le Pechoux C. Small cell lung cancer: new clinical recommendations and current status of biomarker assessment. Eur. J. Cancer 2012, 47(Suppl. 3):S272-S283.
56. Wu J., Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006, 7:R85.
57. Mortazavi A., et al. Comparative genomics modeling of the REST/NRSF repressor network: from single conserved sites to genome-wide repertoire. Genome Res. 2006, 16:1208-1221.
58. Johnson R., et al. Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 2009, 15:85-96.
59. Gopalakrishnan V. REST and RESTless: in stem cells and beyond. Future Neurol. 2009, 4:317-329.
60. Sun Y.M., et al. Distinct profiles of REST interactions with its target genes at different stages of neuronal development. Mol. Biol. Cell 2005, 16:5630-5638.
61. Johnson R., et al. REST regulates distinct transcriptional networks in embryonic and neural stem cells. PLoS Biol. 2008, 6:e256.
62. Yu H.B., et al. Co-assembly of REST and its co-factors at sites of gene repression in embryonic stem cells. Genome Res. 2011, 21:1284-1293.
63. Greenway D.J., et al. RE-1 silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells. Stem Cells 2007, 25:354-363.
64. Klajn A., et al. The REST repression of the neurosecretory phenotype is negatively modulated by BHC80, a protein of the BRAF/HDAC complex. J. Neurosci. 2009, 29:6296-6307.
65. Willert J., et al. A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol. 2002, 2:8.
66. Huang Z., Bao S. Ubiquitynation and deubiquitynation of REST and its roles in cancer. FEBS Lett. 2012, 586:1602-1605.
67. Gates K.P., et al. The transcriptional repressor REST/NRSF modulates hedgehog signaling. Dev. Biol. 2010, 340:293-305.